Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
Clinical trial NCT00689221 · COMPLETED
Trial details
- NCT number
- NCT00689221
- Sponsor
- EMD Serono
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2012-11-01
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.